Retrophin Names Dr. Horacio Plotkin CMO

New York-based Retrophin, a pharmaceutical company, has named Horacio Plotkin, MD, its chief medical officer, effective May 13, according to a Fort Mills Times report.

Advertisement

Most recently, Dr. Plotkin served as executive medical director of clinical research for Alexion Pharmaceuticals. He currently serves as adjunct associate professor of pediatrics and orthopedic surgery at the University of Nebraska Medical Center in Omaha.  

More Articles on Executive Appointments:

10 Spine Device Company Executive Moves
Sonoma Orthopedic Products Hires 3 New Executives
AAOS Names Eight New Executives

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Practice Management

Advertisement

Comments are closed.